<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39378443</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2369-2960</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>JMIR public health and surveillance</Title><ISOAbbreviation>JMIR Public Health Surveill</ISOAbbreviation></Journal><ArticleTitle>Influenza-Like Illness in Lesotho From July 2020 to July 2021: Population-Based Participatory Surveillance Results.</ArticleTitle><Pagination><StartPage>e55208</StartPage><MedlinePgn>e55208</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e55208</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/55208</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Participatory surveillance involves at-risk populations reporting their symptoms using technology. In Lesotho, a landlocked country of 2 million people in Southern Africa, laboratory and case-based COVID-19 surveillance systems were complemented by a participatory surveillance system called "LeCellPHIA" (Lesotho Cell Phone Population-Based HIV Impact Assessment Survey).</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This report describes the person, place, and time characteristics of influenza-like illness (ILI) in Lesotho from July 15, 2020, to July 15, 2021, and reports the risk ratio of ILI by key demographic variables.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">LeCellPHIA employed interviewers to call participants weekly to inquire about ILI. The average weekly incidence rate for the year-long period was created using a Quasi-Poisson model, which accounted for overdispersion. To identify factors associated with an increased risk of ILI, we conducted a weekly data analysis by fitting a multilevel Poisson regression model, which accounted for 3 levels of clustering.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The overall response rate for the year of data collection was 75%, which resulted in 122,985 weekly reports from 1776 participants. ILI trends from LeCellPHIA mirrored COVID-19 testing data trends, with an epidemic peak in mid to late January 2021. Overall, any ILI symptoms (eg, fever, dry cough, and shortness of breath) were reported at an average weekly rate of 879 per 100,000 (95% CI 782-988) persons at risk. Compared to persons in the youngest age group (15-19 years), all older age groups had an elevated risk of ILI, with the highest risk of ILI in the oldest age group (≥60 years; risk ratio 2.6, 95% CI 1.7-3.8). Weekly data were shared in near real time with the National COVID-19 Secretariat and other stakeholders to monitor ILI trends, identify and respond to increases in reports of ILI, and inform policies and practices designed to reduce COVID-19 transmission in Lesotho.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">LeCellPHIA, an innovative and cost-effective system, could be replicated in countries where cell phone ownership is high but internet use is not yet high enough for a web- or app-based surveilance system.</AbstractText><CopyrightInformation>© Abigail R Greenleaf, Sarah Francis, Jungang Zou, Shannon M Farley, Tšepang Lekhela, Fred Asiimwe, Qixuan Chen. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Greenleaf</LastName><ForeName>Abigail R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0002-8261-7025</Identifier><AffiliationInfo><Affiliation>ICAP at Columbia, 60 Haven Ave, New York, NY, 10032, United States, 1 212 342 0505.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Population and Family Health, Mailman School of Public Health, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francis</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6723-482X</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Jungang</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5221-1489</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farley</LastName><ForeName>Shannon M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0003-0321-5974</Identifier><AffiliationInfo><Affiliation>ICAP at Columbia, 60 Haven Ave, New York, NY, 10032, United States, 1 212 342 0505.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Population and Family Health, Mailman School of Public Health, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lekhela</LastName><ForeName>Tšepang</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0007-0523-2096</Identifier><AffiliationInfo><Affiliation>Ministry of Health Lesotho, Maseru, Lesotho.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asiimwe</LastName><ForeName>Fred</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0369-7144</Identifier><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Maseru, Lesotho.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qixuan</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-4199-1766</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Public Health Surveill</MedlineTA><NlmUniqueID>101669345</NlmUniqueID><ISSNLinking>2369-2960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007927" MajorTopicYN="N" Type="Geographic">Lesotho</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Lesotho</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">adult</Keyword><Keyword MajorTopicYN="N">cell phone</Keyword><Keyword MajorTopicYN="N">cellphone</Keyword><Keyword MajorTopicYN="N">data collection</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">influenza-like illness</Keyword><Keyword MajorTopicYN="N">innovation</Keyword><Keyword MajorTopicYN="N">mobile phone</Keyword><Keyword MajorTopicYN="N">participatory surveillance</Keyword><Keyword MajorTopicYN="N">population-based</Keyword><Keyword MajorTopicYN="N">sub-Saharan Africa</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword><Keyword MajorTopicYN="N">technology</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>18</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>18</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>17</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39378443</ArticleId><ArticleId IdType="pmc">PMC11479357</ArticleId><ArticleId IdType="doi">10.2196/55208</ArticleId><ArticleId IdType="pii">v10i1e55208</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization; 2020.  [30-09-2024]. Public health surveillance for COVID-19: interim guidance.https://iris.who.int/handle/10665/337897 URL. Accessed.</Citation></Reference><Reference><Citation>Ibrahim NK. Epidemiologic surveillance for controlling Covid-19 pandemic: types, challenges and implications. J Infect Public Health. 2020 Nov;13(11):1630–1638. doi: 10.1016/j.jiph.2020.07.019. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.019</ArticleId><ArticleId IdType="pmc">PMC7441991</ArticleId><ArticleId IdType="pubmed">32855090</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolinski MS, Crawley AW, Olsen JM, Jayaraman T, Libel M. Participatory disease surveillance: engaging communities directly in reporting, monitoring, and responding to health threats. JMIR Public Health Surveill. 2017 Oct 11;3(4):e62. doi: 10.2196/publichealth.7540. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/publichealth.7540</ArticleId><ArticleId IdType="pmc">PMC5658636</ArticleId><ArticleId IdType="pubmed">29021131</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeil C, Verlander S, Divi N, Smolinski M. The landscape of participatory surveillance systems across the one health spectrum: systematic review. JMIR Public Health Surveill. 2022 Aug 5;8(8):e38551. doi: 10.2196/38551. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/38551</ArticleId><ArticleId IdType="pmc">PMC9391976</ArticleId><ArticleId IdType="pubmed">35930345</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond A, Kim JJ, Sadler H, Vandemaele K. Influenza surveillance systems using traditional and alternative sources of data: a scoping review. Influenza Other Respir Viruses. 2022 Nov;16(6):965–974. doi: 10.1111/irv.13037. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13037</ArticleId><ArticleId IdType="pmc">PMC9530542</ArticleId><ArticleId IdType="pubmed">36073312</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosso F, Castrofino A, Del Castillo G, et al. A comparative study between the incidence and epidemiological features of influenza-like illness and laboratory-confirmed COVID-19 cases in the Italian epicenter (Lombardy) J Infect Public Health. 2021 May;14(5):674–680. doi: 10.1016/j.jiph.2021.02.003. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2021.02.003</ArticleId><ArticleId IdType="pmc">PMC7901382</ArticleId><ArticleId IdType="pubmed">33865059</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg ES, Hall EW, Rosenthal EM, et al. Monitoring coronavirus disease 2019 (COVID-19) through trends in influenza-like illness, laboratory-confirmed influenza, and COVID-19-New York State, excluding New York City, 1 January 2020-12 April 2020. Clin Infect Dis. 2021 Jan 23;72(1):144–147. doi: 10.1093/cid/ciaa684. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa684</ArticleId><ArticleId IdType="pmc">PMC7543876</ArticleId><ArticleId IdType="pubmed">32474578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiemken TL, Shacham E. Identifying potential undocumented COVID-19 using publicly reported influenza-like-illness and laboratory-confirmed influenza disease in the United States: an approach to syndromic surveillance? Am J Infect Control. 2020 Aug;48(8):961–963. doi: 10.1016/j.ajic.2020.05.007. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7211575</ArticleId><ArticleId IdType="pubmed">32437754</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter L, Bello G, Nkambule R, Justman J. HIV general population surveys: shedding light on the status of HIV epidemics and informing future actions. J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S2–S5. doi: 10.1097/QAI.0000000000002701. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAI.0000000000002701</ArticleId><ArticleId IdType="pubmed">34166307</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenleaf AR, Mwima G, Lethoko M, et al. Participatory surveillance of COVID-19 in Lesotho via weekly calls: protocol for cell phone data collection. JMIR Res Protoc. 2021 Sep 27;10(9):e31236. doi: 10.2196/31236. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/31236</ArticleId><ArticleId IdType="pmc">PMC8478051</ArticleId><ArticleId IdType="pubmed">34351866</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesotho Ministry of Health;  [19-09-2024]. Lesotho Population-Based HIV Impact Assessment 2020 (LePHIA 2020): final report.https://phia.icap.columbia.edu/wp-content/uploads/2021/11/260622_LePHIA_RR3_Final_Digital_v2.pdf URL. Accessed.</Citation></Reference><Reference><Citation>The American Association for Public Opinion Research; 2016.  [30-09-2024]. Standard definitions: final dispositions of case codes.https://aapor.org/wp-content/uploads/2022/11/Standard-Definitions20169theditionfinal.pdf URL. Accessed.</Citation></Reference><Reference><Citation>Ritchie H, Ortiz-Ospina E, Beltekian D, et al.  Lesotho: coronavirus pandemic country profile. Our World in Data.  [25-07-2021]. https://ourworldindata.org/coronavirus/country/lesotho URL. Accessed.</Citation></Reference><Reference><Citation>Francis SD, Mwima G, Lethoko M, et al. Comparison of influenza-like illness (ILI) incidence data from the novel LeCellPHIA participatory surveillance system with COVID-19 case count data, Lesotho, July 2020 - July 2021. BMC Infect Dis. 2023 Oct 16;23(1):688. doi: 10.1186/s12879-023-08664-4. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08664-4</ArticleId><ArticleId IdType="pmc">PMC10577929</ArticleId><ArticleId IdType="pubmed">37845641</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Khatib Z, Shah M, Zallappa SN, et al. SMS-based smartphone application for disease surveillance has doubled completeness and timeliness in a limited-resource setting - evaluation of a 15-week pilot program in Central African Republic (CAR) Confl Health. 2018;12:42. doi: 10.1186/s13031-018-0177-6. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13031-018-0177-6</ArticleId><ArticleId IdType="pmc">PMC6199707</ArticleId><ArticleId IdType="pubmed">30386418</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud AS, Chowdhury S, Sojib KH, et al. Participatory syndromic surveillance as a tool for tracking COVID-19 in Bangladesh. Epidemics. 2021 Jun;35:100462. doi: 10.1016/j.epidem.2021.100462. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2021.100462</ArticleId><ArticleId IdType="pmc">PMC8054699</ArticleId><ArticleId IdType="pubmed">33887643</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppenheim B, Gallivan M, Madhav NK, et al. Assessing global preparedness for the next pandemic: development and application of an Epidemic Preparedness Index. BMJ Glob Health. 2019;4(1):e001157. doi: 10.1136/bmjgh-2018-001157. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2018-001157</ArticleId><ArticleId IdType="pmc">PMC6352812</ArticleId><ArticleId IdType="pubmed">30775006</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>